Indian court sends conflicting signals in AstraZeneca disputes
The High Court of Delhi has taken inconsistent positions on issues of evergreening and genus/species patents in case that goes to heart of protections available to life sciences companies
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.